| Impact of Glucagon-like peptide 1 receptor agonists on peripheral arterial disease in people with diabetes mellitus: A narrative review AL Liarakos, A Tentolouris, A Kokkinos, I Eleftheriadou, N Tentolouris Journal of Diabetes and its Complications 37 (2), 108390, 2023 | 9 | 2023 |
| Linezolid: a promising agent for the treatment of multiple and extensively drug-resistant tuberculosis DD Fermeli, TD Marantos, ALD Liarakos, GD Panayiotakopoulos, ... Folia Medica 62, 444, 2020 | 4 | 2020 |
| Antidiabetic medication-induced acute interstitial nephritis: case report and literature search NT Chaudhury, AL Liarakos, K Gopalakrishnan, W Ayub, N Murthy, R Rao British Journal of Diabetes 21 (2), 228-232, 2021 | 3 | 2021 |
| Real-world evaluation of glucose-lowering therapies and the use of weight-adjusted variable rate intravenous insulin infusion in the management of hyperglycaemia in patients … AL Liarakos, P Tran, M Keegan, T Robbins, N Chaudhuri, N Murthy, ... International Journal of Cardiology 370, 26-34, 2023 | 2 | 2023 |
| Implementation of a digital health tool for patients awaiting input from a specialist weight management team: observational study P Hanson, C Summers, A Panesar, AL Liarakos, D Oduro-Donkor, ... JMIR Human Factors 10 (1), e41256, 2023 | 1 | 2023 |
| Real-world outcomes of Omnipod DASH system use in people with type 1 diabetes: Evidence from the Association of British Clinical Diabetologists (ABCD) study AL Liarakos, N Hasan, TSJ Crabtree, L Leelarathna, P Hammond, ... Diabetes Research and Clinical Practice, 111597, 2024 | | 2024 |
| At a glance factsheet: Hybrid closed-loop therapy H Hambling, EG Wilmot, AL Liarakos Diabetes & Primary Care 26, 231-4, 2024 | | 2024 |
| By trainees, for trainees: a gold standard model for IMT3 implementation at a major UK tertiary centre TRRR Henry Brice, Alex Liarakos, Narasimha Murthy Future Healthcare Journal 10 (3), 62, 2023 | | 2023 |
| Novel Dual Incretin Receptor Agonists in the Spectrum of Metabolic Diseases with a Focus on Tirzepatide: Real Game-Changers or Great Expectations? A Narrative Review AL Liarakos, C Koliaki Biomedicines 11 (7), 1875, 2023 | | 2023 |
| ABCD News D Patel, U Dashora, R Reeve, A Liarakos British Journal of Diabetes 23 (1), 51-62, 2023 | | 2023 |
| Can we predict medical treatment failure in Graves AL Liarakos, A Foka, A Mohamed, F Kavvoura Endocrine Abstracts 90, 2023 | | 2023 |
| ABCD News D Patel, U Dashora, R Reeve, A Liarakos, P Choudhary British Journal of Diabetes 22 (2), 152-162, 2022 | | 2022 |
| Important learning lessons from a rare case of hypoparathyroidism AL Liarakos, P Tran, T Page, R Rao, N Murthy Endocrine Abstracts 86, 2022 | | 2022 |
| Late maternal diagnosis of DiGeorge syndrome with congenital hypoparathyroidism following antenatal detection of the same 22q11. 2 microdeletion syndrome in the fetus AL Liarakos, P Tran, R Rao, N Murthy BMJ Case Reports CP 15 (5), e250350, 2022 | | 2022 |
| Delayed onset of neurogenic pulmonary oedema following an evolving ischaemic stroke AL Liarakos, P Tran BMJ Case Reports CP 15 (2), e247522, 2022 | | 2022 |
| Safety, efficacy and feasibility of a modified variable rate intravenous insulin infusion regime in treating hyperglycaemia in acute coronary syndrome AL Liarakos, P Tran, M Keegan, T Robbins, N Murthy, H Randeva, ... DIABETOLOGIA 64 (SUPPL 1), 340-340, 2021 | | 2021 |
| A district general hospital real-world experience of the use of semaglutide in patients with type 2 diabetes AL Liarakos, L Smith, K Patel, H Mani, M Pierides DIABETIC MEDICINE 37, 131-131, 2020 | | 2020 |
| Clinical care and other categories posters: Incretin therapies AL Liarakos | | 2020 |
| Health in the UK H Mani, AL Liarakos, MJ Levy The Lancet 394 (10201), 828, 2019 | | 2019 |
| Randomised Controlled Trials in women with polycystic ovary syndrome do not represent the majority of patients who are in a primary care setting: systematic review and meta … AL Liarakos, M Levy, H Mani Endocrine Abstracts 63, 2019 | | 2019 |
Anastasia ArmeniPostdoctoral ResearcherVerified email at upatras.gr
